Faeth Therapeutics (FTH) Return on Capital Employed (2021 - 2026)

Faeth Therapeutics' (FTH) quarterly Return on Capital Employed came in at 265.38% in Q1 2026, down 149.98% on a QoQ basis from 106.16% in Q4 2025.

Faeth Therapeutics (FTH) Return on Capital Employed (2021 - 2026) Analysis & Trends

Faeth Therapeutics (FTH) has 6 years of Return on Capital Employed data on file, last reported at 265.38% in Q1 2026.

Quarterly Return on Capital Employed changed N/A year-over-year to 265.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 265.38% (changed N/A YoY) and the FY2025 annual result came in at 74.59%, down 1466.0% from the prior year.
Return on Capital Employed declined to 265.38% in Q1 2026, from 106.16% in the prior quarter.
In the past five years, Return on Capital Employed ranged from a high of 29.16% in Q1 2022 to a low of 265.38% in Q1 2026.
A 5-year average of 70.84% and a median of 52.86% in 2023 frame the typical range for Return on Capital Employed.
Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 399 bps — and 2025, when it plunged 3782 bps.
Tracing FTH's Return on Capital Employed over 5 years: stood at 43.82% in 2022, then declined by 17 bps to 51.21% in 2023, then sank by 45 bps to 74.36% in 2024, then slumped by 43 bps to 106.16% in 2025, then plunged by 150 bps to 265.38% in 2026.
The last three Return on Capital Employed figures came in at 265.38% (Q1 2026), 106.16% (Q4 2025), and 101.41% (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.76%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	10.74%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-38.20%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	13.68%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	26.09%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-6.85%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-50.93%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	7.88%
10	Faeth Therapeutics	179.31 Mn	179.31 Mn	-	-119.91%

Download Data